Tuesday, March 3, 2015

Blood Cancer Journal - Table of Contents alert Volume 5 February 2015

If you are unable to see the message below, click here to view.
Blood Cancer Journal

TABLE OF CONTENTS

Volume 5, February 2015

In this issue
Review
Original Article
Letters to the Editor
Errata
Sign up for e-alerts Sign up for e-alerts
Web feed
Advertisement
2013 IMPACT FACTOR 5.177

Cell Death & Disease is an online-only, open access journal seeking to promote diverse and integrated areas of experimental and internal medicine with its specialities, including cancer, cancer metabolism, immunity and neuroscience.

Explore the benefits of submitting your next research article: http://bit.ly/1t4BIFJ

Review

Top

B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?

P J Hengeveld and M J Kersten

Blood Cancer J 2015 5: e282; 10.1038/bcj.2015.3

Abstract | Full Text

Original Article

Top

PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival

Z -Z Yang, D M Grote, S C Ziesmer, B Xiu, A J Novak and S M Ansell

Blood Cancer J 2015 5: e281; 10.1038/bcj.2015.1

Abstract | Full Text

Letters to the Editor

Top

Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy

Z R Chalmers, S M Ali, R S Ohgami, P V Campregher, G M Frampton, R Yelensky, J A Elvin, N A Palma, R Erlich, J-A Vergilio, J Chmielecki, J S Ross, P J Stephens, R Hermann, V A Miller and C R Miles

Blood Cancer J 2015 5: e278; 10.1038/bcj.2014.95

Full Text

Immortal time bias in retrospective analysis: comment on ‘Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma’

P-Y Hsieh, C-J Liu and C-J Teng

Blood Cancer J 2015 5: e283; 10.1038/bcj.2015.4

Full Text

t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs

T Narita, A Inagaki, T Kobayashi, Y Kuroda, T Fukushima, M Nezu, S Fuchida, H Sakai, N Sekiguchi, I Sugiura, Y Maeda, H Takamatsu, N Tsukamoto, D Maruyama, Y Kubota, M Kojima, K Sunami, T Ono, M Ri, K Tobinai and S Iida

Blood Cancer J 2015 5: e285; 10.1038/bcj.2015.6

Full Text

Absence of natural intracellular retinoids in mouse bone marrow cells and implications for PML-RARA transformation

H Niu, J Chacko, G Hadwiger and J S Welch

Blood Cancer J 2015 5: e284; 10.1038/bcj.2015.2

Full Text

Errata

Top

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study

A J Greenberg, S Philip, A Paner, S Velinova, A Badros, R Catchatourian, R Ketterling, R A Kyle, S Kumar, C M Vachon and S V Rajkumar

Blood Cancer J 2015 5: e279; 10.1038/bcj.2015.8

Full Text

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

M M Patnaik, E A Wassie, E Padron, F Onida, R Itzykson, T L Lasho, O Kosmider, C M Finke, C A Hanson, R P Ketterling, R Komrokji, A Tefferi and E Solary

Blood Cancer J 2015 5: e280; 10.1038/bcj.2015.9

Full Text

Advertisement
2013 IMPACT FACTOR 2.884

Blood Cancer Journal is an online-only, open access journal seeking to publish articles of the highest quality concerning hematologic malignancies and related disorders.

Explore the benefits of submitting your next research article: http://bit.ly/1FpVSOx

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: